技術(shù)文章您現(xiàn)在的位置：首頁 > 技術(shù)文章 > BioXCell產(chǎn)品介紹--RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)

BioXCell產(chǎn)品介紹--RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)

更新時(shí)間：2023-10-31 點(diǎn)擊次數(shù)：625次

BioXCell熱銷產(chǎn)品--RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)

產(chǎn)品描述：

10F.9G2™-CP001單克隆抗體是原始10F.9G2™單克隆抗體的重組嵌合型抗體。可變結(jié)構(gòu)域序列與原始10F.9G2™克隆號相同，但是恒定區(qū)序列已經(jīng)從大鼠IgG2b變?yōu)樾∈驣gG1。10F.9G2™-CP001單克隆抗體在Fc片段中也含有D265A突變，使其無法與內(nèi)源性Fcγ受體結(jié)合。

10F.9G2™-CP001單克隆抗體與小鼠PD-L1（程序性死亡配體1，也稱為B7-H1或CD274）反應(yīng)。PD-L1是屬于Ig超家族的B7家族的I型跨膜蛋白，分子量為40kDa。PD-L1在T淋巴細(xì)胞、B淋巴細(xì)胞、NK細(xì)胞、樹突狀細(xì)胞以及IFNγ刺激的單核細(xì)胞、上皮細(xì)胞和內(nèi)皮細(xì)胞上表達(dá)。PD-L1與CD4和CD8胸腺細(xì)胞以及活化的T和B淋巴細(xì)胞和骨髓細(xì)胞上的受體PD-1結(jié)合。PD-L1與PD-1的結(jié)合導(dǎo)致抑制TCR介導(dǎo)的T細(xì)胞增殖和細(xì)胞因子產(chǎn)生。PD-L1被認(rèn)為在腫瘤免疫逃逸中起著重要作用。誘導(dǎo)的PD-L1表達(dá)在許多腫瘤中很常見，并導(dǎo)致腫瘤細(xì)胞對CD8+ T細(xì)胞介導(dǎo)的裂解的抗性增加。在黑色素瘤的小鼠模型中，可以通過用阻斷PD-L1和PD-1之間相互作用的抗體進(jìn)行治療，暫時(shí)抑制腫瘤生長。10F.9G2™單克隆抗體已被證明可以阻斷PD-L1和PD-1之間以及PD-L1和B7-1之間的相互作用（CD80）。

產(chǎn)品詳情：

產(chǎn)品名稱	RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A) /欣博盛生物
產(chǎn)品貨號	CP001
產(chǎn)品規(guī)格	1mg
反應(yīng)種屬	Mouse
克隆號	10F.9G2™-CP001
同種型	Mouse IgG1(switched from rat IgG2b)
免疫原	Mouse CD274
實(shí)驗(yàn)應(yīng)用	in vivo PD-L1 blockade* Immunofluorescence* Immunohistochemistry (frozen)* Flow cytometry* Western blot* *Reported for the original rat IgG2b 10F.9G2 antibody
產(chǎn)品形式	PBS, pH 7.0,Contains no stabilizers or preservatives
純度	>95%, Determined by SDS-PAGE
聚合	<5%, Determined by SEC
無菌處理	0.2 µm filtration
純化方式	Protein A
分子量	150 kDa
小鼠病原檢測	Ectromelia/Mousepox Virus: Negative Hantavirus: Negative K Virus: Negative Lactate Dehydrogenase-Elevating Virus: Negative Lymphocytic Choriomeningitis virus: Negative Mouse Adenovirus: Negative Mouse Cytomegalovirus: Negative Mouse Hepatitis Virus: Negative Mouse Minute Virus: Negative Mouse Norovirus: Negative Mouse Parvovirus: Negative Mouse Rotavirus: Negative Mycoplasma Pulmonis: Negative Pneumonia Virus of Mice: Negative Polyoma Virus: Negative Reovirus Screen: Negative Sendai Virus: Negative Theiler’s Murine Encephalomyelitis: Negative
保存條件	抗體原液保存在4°C，不能冷凍保存。
推薦抗體稀釋液	InVivoPure pH 7.0 Dilution Buffer（貨號IP0070）

該產(chǎn)品自上市已被多篇SCI文獻(xiàn)引用，品質(zhì)有保證，以下是部分已發(fā)表的文獻(xiàn)引用：

應(yīng)用

文章

體內(nèi)PD-L1阻斷

(in vivo PD-L1 blockade)

1. Grasselly, C., et al. (2018). 'The Antitumor Activity of Combinations of Cytotoxic

Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent' Front

Immunol 9: 2100.

2. Stathopoulou, C., et al. (2018). 'PD-1 Inhibitory Receptor Downregulates Asparaginyl

Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory

T Cells' Immunity 49(2): 247-263 e247.

3. Jaworska, K., et al. (2015). 'Both PD-1 ligands protect the kidney from ischemia

reperfusion injury' J Immunol 194(1): 325-333.

4. Kim, J., et al. (2015). 'Memory programming in CD8(+) T-cell differentiation is

intrinsic and is not determined by CD4 help' Nat Commun 6: 7994.

5. Zander, R. A., et al. (2015). 'PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk

Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity' Cell

Host Microbe 17(5): 628-641.

體內(nèi)PD-L1阻斷，流式細(xì)胞術(shù)

(in vivo PD-L1 blockade, Flow

Cytometry)

1. Aloulou, M., et al. (2016). 'Follicular regulatory T cells can be specific for the

immunizing antigen and derive from naive T cells' Nat Commun 7: 10579.

2. Ngiow, S. F., et al. (2015). 'A Threshold Level of Intratumor CD8+ T-cell PD1

Expression Dictates Therapeutic Response to Anti-PD1' Cancer Res 75(18): 3800-3811.

3. Rutigliano, J. A., et al. (2014). 'Highly pathological influenza A virus infection is

associated with augmented expression of PD-1 by functionally compromised

virus-specific CD8+ T cells' J Virol 88(3): 1636-1651.

體內(nèi)PD-L1阻斷，免疫熒光

(in vivo PD-L1 blockade,

Immunofluorescence)

1.Willimsky, G., et al. (2013). 'Virus-induced hepatocellular carcinomas cause

antigen-specific local tolerance' J Clin Invest 123(3): 1032-1043.

免疫組織化學(xué)（冷凍），免疫熒光

(Immunohistochemistry (frozen),

Immunofluorescence)

1.Riella, L. V., et al. (2011). 'Essential role of PDL1 expression on nonhematopoietic

donor cells in acquired tolerance to vascularized cardiac allografts' Am J Transplant

11(4): 832-840.

<a class=

更多產(chǎn)品詳情請聯(lián)系 BioXCell 中國授權(quán)代理——欣博盛生物

上一篇：我的實(shí)驗(yàn)樣本可以用于CUT&RUN嗎? 四大因素需考量

下一篇：RecombiMAb anti-mouse VEGFR-2抗體

返回列表>>

香蕉综合在线丨亚洲色欲一区二区三区在线观看丨国产十八禁在线观看免费丨99国产精品白浆在线观看免费丨成人涩涩视频丨99久久久精品国产一区二区丨成本人无码h无码动漫在线网站丨国产一级免费大片

BioXCell產(chǎn)品介紹--RecombiMAb anti-mouse PD-L1 (B7-H1) (D265A)